高级检索
当前位置: 首页 > 详情页

A thermo-sensitive hydrogel targeting macrophage reprogramming for sustained osteoarthritis pain relief

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 统计源期刊 ◇ CSCD-C ◇ 卓越:领军期刊

机构: [1]Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China. [2]Department of Anaesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China. [3]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. [4]Department of Orthopedics and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China. [5]Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China. [6]West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
出处:
ISSN:

关键词: Chronic pain Dorsal root ganglion Macrophages Osteoarthritis Thermo-sensitive hydrogel Neuroinflammation Drug delivery Pain management

摘要:
Osteoarthritis (OA) causes chronic pain that significantly impairs quality of life, with current treatments often proving insufficient and accompanied by adverse effects. Recent research has identified the dorsal root ganglion (DRG) and its resident macrophages as crucial mediators of chronic OA pain through neuroinflammation driven by macrophage polarization. We present a novel injectable thermo-sensitive hydrogel system, KAF@PLEL, designed to deliver an anti-inflammatory peptide (KAF) specifically to the DRG. This biodegradable hydrogel enables sustained KAF release, promoting the reprogramming of DRG macrophages from pro-inflammatory to anti-inflammatory phenotypes. Through comprehensive in vitro and in vivo studies, we evaluated the hydrogel's biocompatibility, effects on macrophage polarization, and therapeutic efficacy in chronic OA pain management. The system demonstrated significant capabilities in preserving macrophage mitochondrial function, suppressing neuroinflammation, alleviating chronic OA pain, reducing cartilage degradation, and improving motor function in OA rat models. The sustained-release properties of KAF@PLEL enabled prolonged therapeutic effects while minimizing systemic exposure and side effects. These findings suggest that KAF@PLEL represents a promising therapeutic approach for improving outcomes in OA patients through targeted, sustained treatment.© 2025 The Authors.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学
第一作者:
第一作者机构: [1]Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China. [2]Department of Anaesthesiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Anaesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China. [5]Laboratory of Anaesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anaesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65780 今日访问量:0 总访问量:5151 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号